Records containing: Phenylketonuria
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2018-09-10A Phase 3, Open-Label, Randomized, Multi-Center Study to Assess the Safety & Tolerability of an Induction, Titration, and Maintenance Dose Regimen of BMN 165 Self Administered by Adults With PKU Not Previously Treated With BMN 165
-
CLINICAL_TRIALS study record update · 2018-06-18Effects of Sapropterin on Brain and Cognition in Individuals With Phenylketonuria
-
CLINICAL_TRIALS study record update · 2018-02-05The Brain, Neurological Features and Neuropsychological Functioning in Adults With Sapropterin Dihydrochloride Treated Phenylketonuria
-
CLINICAL_TRIALS study record update · 2018-01-04The Effects of Kuvan on Functional Brain Connectivity in Individuals With Phenylketonuria (PKU)
-
CLINICAL_TRIALS study record update · 2017-03-03Phase 2 Study of Glycomacropeptide vs. Amino Acid Diet for the Management of PKU
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-02-23Observational, Investigator Initiated, Monocentric Study of the Endothelial Dysfunction in Adolescent and Adult Patients With Phenylketonuria Due to Phenylalanine Hydroxylase Deficiency
-
CLINICAL_TRIALS study record update · 2017-02-01A Phase I, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Subcutaneous Doses of rAvPAL-PEG in Subjects With Phenylketonuria
-
CLINICAL_TRIALS study record update · 2016-05-12A Phase IIIb, Multicentre, Open-Label, Randomized, Controlled Study of the Efficacy, Safety, and Population Pharmacokinetics of Sapropterin Dihydrochloride (Kuvan®) in Phenylketonuria (PKU) Patients <4 Years Old.
-
CLINICAL_TRIALS study record update · 2016-02-17Neuropsychological and Quality of Life Outcomes in Untreated Adults With Mild Hyperphenylalaninemia (MHP)/Phenylketonuria (PKU) With Phenylalanine Levels Between 360 and 600 µmol/L Caused by Phenylalanine Hydroxylase (PAH) Deficiency.
-
CLINICAL_TRIALS study record update · 2016-02-12A Multicenter, Double-Blind, Placebo-Controlled, Randomized, 2-Arm Phase IIa Pilot Trial Assessing the Effect of Sapropterin on Cognitive Abilities in Young Adults With Phenylketonuria
-
CLINICAL_TRIALS study record update · 2016-02-01A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
-
CLINICAL_TRIALS study record update · 2015-12-11Biological Variation of Phenylalanine in Patients With Hyperphenylalaninemia
-
CLINICAL_TRIALS study record update · 2015-12-11The Impact of Docosahexaenoic Acid on Neuropsychological Status in Females With Phenylketonuria
-
CLINICAL_TRIALS study record update · 2015-07-07Bone Mineral Density in Adults With Hyperphenylalaninemia on Kuvan Therapy
-
CLINICAL_TRIALS study record update · 2015-06-19The Brain, Neurological Features and Neuropsychological Functioning in Adults With Phenylketonuria: A Pilot Study
-
CLINICAL_TRIALS study record update · 2015-05-12A Pilot Study of FDG PET Findings in Patients With Phenylketonuria Before and After BH4 Supplementation
-
CLINICAL_TRIALS study record update · 2014-10-16The Effects of an Acute Bout of Moderate Intensity Exercise on Plasma Amino Acids in Subjects With Phenylketonuria
-
CLINICAL_TRIALS study record update · 2014-08-28The Ability of Kuvan® (Sapropterin Dihydrochloride) to Prevent Meal-induced Lipid Peroxidation and Endothelial Dysfunction in Patients With Phenylketonuria: a Pilot Study
-
CLINICAL_TRIALS study record update · 2014-08-20The Early History of Universal Screening for Metabolic Disorders
-
CLINICAL_TRIALS study record update · 2014-08-20Baseline Evaluation and Long-term Follow-up of Nutritional Status and Neurotransmitter Concentrations in Phenylketonuria Patients Initiating Treatment With Sapropterin Dihydrochloride (KuvanTM), a Tetrahydrobiopterin Analog.
-
CLINICAL_TRIALS study record update · 2014-07-28A Phase III Non-comparative Open-label Clinical Study to Evaluate the Response to and Safety of Kuvan (Sapropterin Dihydrochloride) After 6 Weeks of Treatment in Patients of 4 to 18 Years of Age With Phenylketonuria Who Have Elevated Blood Phenylalanine Levels
-
CLINICAL_TRIALS study record update · 2013-12-05Behavioral Effects of Kuvan in Children With Mild Phenylketonuria
-
CLINICAL_TRIALS study record update · 2013-09-105-year Follow-up of the Comparison of Life and Physical Health in Adult Patients With PKU and Healthy Age Matched Controls
-
CLINICAL_TRIALS study record update · 2013-08-01ENDURE: A Phase IV, Prospective, Open-label, Uncontrolled, Multi-centre Cohort Trial to Assess the Responsiveness of Subjects With Phenylketonuria (PKU) to Treatment With Kuvan® 20 mg/kg/Day for 28 Days
-
CLINICAL_TRIALS study record update · 2013-01-18Pilot Study to Evaluate the Effects of Kuvan on Adult Individuals With Phenylketonuria With Measurable Maladaptive Behaviors